Home/ Supplements/ Phosphorus/ Cellular Forte

Cellular Forte

product on market Capsule Integrative Therapeutics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains essential minerals like calcium, magnesium, and phosphorus, which support bone health and cellular function. It also includes IP-6, though research on its specific systemic benefits is limited. Overall, the evidence coverage for this specific ingredient combination is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cellular Forte
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
120
Servings
Non-Nutrient/Non-Botanical
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrate
1 Gram(s) (1% DV)
Calcium
131 mg (10% DV)
192 mg (15% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:3)
40 mg (10% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
IP-6
800 mg
220 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)

Other Ingredients

Cellulose Hypromellose Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendation: Adults take 2 capsules twice daily. Best taken on an empty stomach.

Warnings & Precautions

Keep out of reach of children.

Safety sealed with inner seal. Do not use if seal is broken or missing.

If you are pregnant, nursing, or taking any medications, consult a healthcare professional before use.

Formulation Notes

Vegan

Contains no wheat, gluten, soy, dairy, or artificial colors, or flavors.

With IP-6 and Inositol

Additional Information

For more information, please visit integrativepro.com.

Keep tightly closed. Store at room temperature. Avoid excessive heat and direct sunlight.

Quality Global Sourcing Bottled & Tested in the USA

Metadata

Product Details

UPC / SKU8 71791 00098 8
DSLD Entry Date2023-06-22
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandIntegrative Therapeutics
DSLD ID292739
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

Uridine Monophosphate Capsules 250 mg
Nootropics Depot · Capsule
100
IP-6
Wonder Laboratories · Capsule
100
Calcium Phosphorus
Wonder Laboratories · Capsule
100
Calcium Phosphorus
Wonder Laboratories · Capsule
100
Calcium Phosphorus
Wonder Laboratories · Capsule
100
View all Phosphorus products →
Phosphorus research Best Phosphorus All Phosphorus products More from Integrative Therapeutics View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.